Behavioral communication treatment is the standard of care for stroke-induced aphasia. In spite of considerable body of research, the effectiveness of aphasia treatment was debated for several decades. However, several recent studies, including large-scale meta-analyses and phase III trials provide strong evidence in favor of aphasia treatment. In spite of this evidence, it is clear that there is a considerable range in aphasia treatment response across patients. In the current lecture, I will report results from a recently completed trial aimed at understanding patient characteristics related to individual aphasia treatment response. The purpose of this work is twofold: 1. To inform clinicians about important prognostic indicators, which may aid in the design of personalized aphasia treatment and patient counseling; and 2. To better understand the neurobiological mechanisms that support treated recovery from aphasia. If time permits, I will also discuss a recently completed phase II trial on using transcranial direct current stimulation as an adjuvant to aphasia treatment in stroke.


Julius Fridriksson is a professor and endowed chair (SmartState) in the Department of Communication Sciences and Disorders, University of South Carolina. His scientific interests are mainly in the area of aphasia rehabilitation, neurobiology of language, and language decline associated with aging.

Fridriksson serves as the director of the Center for the Study of Aphasia Recovery (C-STAR) and co-director of the McCausland Center for Brain Imaging. Fridriksson’s work has been continuously funded by the NIH since 2002.

Register for the webinar here: https://zoom.us/webinar/register/WN_lyn5LVt9RlqSyE-mRO3Lxw